CSL Limited CSL Limited

CSL Limited

CSL

Peringkat dalam Saham #363
CSL Limited operates as a global biopharmaceutical company, engaged in the... CSL Limited operates as a global biopharmaceutical company, engaged in the research, development, manufacturing, marketing, and distribution of diverse pharmaceutical and allied products. Its extensive international footprint includes key markets such as Australia, the United States, Germany, the United Kingdom, Switzerland, and China. The company is structured into two principal operating segments: CSL Behring and CSL Seqirus. CSL Behring focuses on plasma-derived therapies, encompassing both plasma products and recombinant treatments. This segment also conducts significant research into both plasma and non-plasma therapeutics and derives revenue from intellectual property licensing and royalties. In contrast, CSL Seqirus is dedicated to the manufacturing and worldwide distribution of non-plasma biotherapeutic products, alongside developing a range of influenza-related solutions. Founded in 1916, CSL Limited maintains its corporate headquarters in Parkville, Australia.
Harga Saham
$137.83
Kapitalisasi Pasar
$66.14B
Perubahan (1 hari)
0.87%
Perubahan (1 tahun)
-3.78%
Negara
AU
Perdagangan CSL Limited (CSL)

Kategori

Healthcare
Riwayat harga saham CSL Limited (CSL)
Harga penutupan tertinggi: $130.93 pada 2026-10-01

Harga penutupan terendah: $0.58 pada 1994-05-01
Riwayat harga saham CSL Limited dari 1994 hingga 2026
Performa harga saham tahunan
Tahun Performa
2026 (TTM) -11.03%
2025 -33.22%
2024 -3.40%
2023 -7.34%
2022 -5.55%
2021 -4.35%
2020 13.64%
2019 48.92%
2018 19.64%
2017 51.86%
2016 -2.99%
2015 3.42%
2014 17.66%
2013 7.48%
2012 72.89%
2011 -9.64%
2010 27.38%
2009 31.88%
2008 -30.73%
2007 91.54%
2006 59.34%
2005 39.55%
2004 69.88%
2003 10.97%
2002 -54.53%
2001 23.69%
2000 47.80%
1999 54.18%
1998 35.94%
1997 57.11%
1996 56.41%
1995 57.26%
1994 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$527.18 23.62%
US
$251.29 835.90%
US
$890.85 9.42%
NL
$765.49 8.80%
CH
$262.11 -7.91%
BE